Has Devang Desai, MD received payments from drug or device companies?

Yes. Drug and device makers reported $206,268 in general payments to Devang Desai, MD across 875 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Devang Desai, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Devang Desai, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Devang Desai, MD

Cardiovascular Disease · Reno, NVNPI 1013110998

Payments from drug & device makers

$206,268in general payments, 2019–2025

Across 875 payments — averaging $235.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$116K
Edwards Lifesciences$69K
Medtronic$8K
Boston Scientific$3K
Abbott$2K
Angiodynamics, Inc.$2K
plus $6K from 41 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	153	$116,101
Edwards Lifesciences	238	$69,319
Medtronic(2 entities)	91	$7,797
Boston Scientific	68	$2,566
Abbott	35	$2,140
Angiodynamics, Inc.	2	$1,902
Novartis	71	$1,245
Abiomed	12	$515
Actelion Pharmaceuticals US, Inc.	21	$467
Amgen	20	$389
E.r. Squibb & Sons, L.L.C.	17	$351
Boehringer Ingelheim	11	$332
Pfizer	17	$319
Merck	13	$294
Bayer	6	$203
Scpharmaceuticals Inc.	9	$189
AstraZeneca(2 entities)	11	$183
Alnylam Pharmaceuticals Inc.	8	$173
Biotronik Inc.	4	$171
Atricure, Inc.	8	$163
Philips North America LLC	5	$136
United Therapeutics Corporation	6	$130
GE HealthCare	2	$124
Esperion Therapeutics, Inc.	7	$121
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	4	$114
Regeneron Healthcare Solutions, Inc.	8	$109
Cardiva Medical, Inc.	2	$70
Shockwave Medical, Inc	3	$67
Penumbra, Inc.	1	$64
Cvrx, Inc.	2	$50
Kiniksa Pharmaceuticals International, PLC	2	$49
Irhythm Technologies, Inc.	2	$46
Akcea Therapeutics, Inc.	1	$44
Bridgebio Pharma, Inc.	1	$36
Biosense Webster, Inc.	1	$32
Amarin Pharma, Inc.	2	$32
Heartflow, Inc.	1	$31
Livanova USA, Inc.	1	$28
W. L. Gore & Associates, Inc.	1	$25
Cardinal Health 200 LLC	1	$21
Baxter Healthcare	1	$21
Lexicon Pharmaceuticals, Inc.	1	$20
Kowa Pharmaceuticals America, Inc.	1	$18
Tactile Systems Technology Inc	1	$18
Lilly USA, LLC	1	$16
Novo Nordisk	1	$15
Cardiovascular Systems Inc.	1	$11

How this compares

$206,268 in reported general payments places this provider in the 95th percentile of 165 cardiovascular disease providers in Nevada.

See all cardiovascular disease providers in Nevada →

Medicare billing

Part B allowed, 2024

$535,802

Medicare patients

1,030

Services billed

3,351

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Reno

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →